• Anex (2008). Towards a National NSP Strategic Framework: Discussion Paper, Anex, Melbourne.

  • Australian Federation of Aids Organisation Inc. (2008). Briefing paper, Hepatitis B.

  • Australian Injecting and Illicit Drug Users' League (2006). Peer Education Among Illicit Drug Users, Australian Injecting and Illicit Drug Users' League, Canberra.

  • Australian Institute of Health and Welfare (2008). 2007 National Drug Strategy Household Survey: First results. Drug Statistics Series No. 20 Cat. No. PHE 98, AIHW, Canberra.

  • Australian National Council on Drugs (2002). NSPs: position paper, ANCD, Canberra.

  • Black, E., Roxburgh, A., Degenhardt, L., Bruno, R., Campbell, G., de Graff, B., Fetherston, J., Kinner, S., Moon, C., Quinn, B., Richardson, M., Sindicich, N. and White, N. (2008). Australian Drug Trends 2007: Findings from the IDRS, National Drug and Alcohol Research Centre, Sydney.

  • Bluthenthal, R., Ridgeway, G., Schell, T. L., Andersen, R., Flynn, N.M. and Kral, A.H. (2007a). "Examination of the association between syringe exchange program (SEP) dispensation policy and SEP service user-level syringe coverage among injection drug users" in Addiction, v. 102, no. 4, April 2007: 638 – 646.

  • Bluthenthal, R., Anderson, R., Flynn, N.M. and Kral, A.H. (2007b). "Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program service users" in Drug and Alcohol Dependence, v. 89, no. 2, July 2007: 214 – 222.

  • Commonwealth of Australia (2004). The National Drug Strategy: Australia's Integrated Framework 2004-2009, Commonwealth of Australia, Canberra.

  • Commonwealth of Australia (2010a). The Sixth National HIV Strategy 2010 – 2013, Commonwealth of Australia, Canberra.

  • Commonwealth of Australia (2010b). The Third National Hepatitis C Strategy 2010-2013, Commonwealth of Australia, Canberra. Top of page

  • Commonwealth of Australia (2010c). The Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2009-2013. Commonwealth of Australia, Canberra.

  • Commonwealth of Australia (2010d). The National Hepatitis B Strategy 2010-2013, Commonwealth of Australia, Canberra.

  • Commonwealth of Australia (2008). Intergovernmental Committee on drugs on the National Drug Strategy website (www.nationaldrugstrategy.gov.au), Commonwealth of Australia: Canberra, (viewed November 2008).

  • Consumer Focus Collaboration (2001). The evidence supporting consumer participation in health, National Resource Centre for Consumer Participation in Health, Melbourne.

  • Cook, C. and Kanaef, N. (2008). Global State of Harm Reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics, International Harm Reduction Association, London. Council of Australian Governments (2008a).

  • Council of Australian Governments (2008a). Council of Australian Governments Meeting, Canberra, 29 November 2008, Australian Government. PDF available at COAG website (www.coag.gov.au) (viewed 31 March 2009).

  • Council of Australian Governments (2008b). National Healthcare Agreement, Australian Government.

  • Crofts, N., Aitken, C. and Kaldor, J. (1999). "The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.", in Medical Journal of Australia 1999, 170: 220 – 221.

  • Dolan, K., MacDonald, M., Silins, E. and Topp, L. (2005). NSP: A review of the evidence, Commonwealth Government Department of Health and Ageing, Canberra.

  • Fowler, D., Spina, A. and Dolan, K. (2006). NSW NSP Strategic Planning Report (publisher details unavailable).

  • Gidding, H., Warlow, M., MacIntyre, C., Bakehouse, J., Gilbert, G., Quinn, H. and McIntyre, P. The impact of a new universal infant and school based adolescent hepatitis B vaccination program in Australia. Vaccine 2007.

  • Gowing, L., Proudfoot, H., Henry-Edwards, S. and Teesson, M. (2001). Evidence Supporting Treatment: the effectiveness of interventions for illicit drug use, Australian National Council on Drugs, Canberra. Top of page

  • Hagan, H., Thiede, H., Weiss, N.S., Hopkins, S.G., Duchin, J.S. and Alexander, E. R. (2001). "Sharing of drug preparation equipment as a risk factor for hepatitis C" in American Journal of Public Health 2001; 91(1): 42 – 46.

  • Health Outcomes International, National Centre for HIV Epidemiology and Clinical Research and Drummond, M. (2002). Return on Investment in NSPs in Australia Report, Commonwealth Department of Health and Ageing, Canberra.

  • Hepatitis Victoria (2008). Impact: Information about hepatitis C, Hepatitis Victoria, Melbourne.

  • Iversen, J., Deakin, R., and Maher, L. (2008). Australian NSP Survey: Prevalence of HIV, HCV and injecting and sexual behaviour among injecting drug users at NSPs, National Data Report, 2003-2007, National Centre in HIV Epidemiology and Clinical Research, Sydney.

  • Körner H, Treloar C. (2004). 'Needle and syringe programmes in the local media: 'needle anger' versus 'effective education in the community'. International Journal of Drug Policy. 15, 46-55.

  • Maher, L., Jalaludin, B., Chant, K., Jaysuria, R., Sladden, T., Kaldor, J. and Sargent, P. (2006). "Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia", Addiction, 101, 1499 – 1508.

  • Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis (2006). Hepatitis C Virus Projections Working Group: Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2006, Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, Hepatitis C Sub-Committee, Canberra.

  • Moore, T.J. (2005). . Monograph No. 01: What is Australia's "drug budget"? The policy mix of illicit drug-related government spending in Australia. DPMP Monograph Series. Turning Point Alcohol and Drug Centre, Fitzroy.

  • National Centre in HIV Epidemiology and Clinical Research (2009). Return on investment 2: Evaluating the cost-effectiveness of needle and syringe programs in Australia 2009. The University of New South Wales, Sydney.

  • Parliamentary Joint Committee on the Australian Crime Commission (2007). Inquiry into the manufacture, importation and use of amphetamines and other synthetic drugs (AOSD) in Australia, Commonwealth of Australia, Canberra.

  • Strike, C., Leonard, L., Millson, M., Anstice, S., Berkeley, N., and Medd, E. (2006). Ontario Needle Exchange Programs: Best Practice Recommendations, Ontario Needle Exchange Coordinating Committee, Toronto.

  • Thorpe, L.E., Bailey, S.L., DeZheng, H., Monterroso, E. and Ouellet, L. (2001). "Injection-related risk behaviours in young urban and suburban injection drug users in Chicago 1997-1999" in Journal of Acquired Immune Deficiency Syndromes, 2001; 27(1): 71 – 78.

  • Treloar C, Cao W. (2005). 'Access to harm reduction services and 'hidden' injectors: barriers to NSP use in a high drug use area of Sydney, New South Wales' International Journal of Drug Policy, 16: 308–15.Top of page

  • Treloar, C. and Fraser, S. (2007). "Public opinion on NSPs: avoiding assumptions for policy and practice", Drug and Alcohol Review, 26:4.

  • Treloar C, Körner H. (2005). 'NSPs and the media: a case study of balanced and accurate reporting?' [letter] Australian and New Zealand Journal of Public Health, 29, 489-490.

  • United National General Assembly (2001). Declaration of Commitment on HIV/AIDS, agreed at the United Nations General Assembly Special Session on HIV/AIDS 25-27 June 2001, United Nations, New York.

  • Wodak, A. and Cooney, A. (2004). Evidence for action technical papers: Effectiveness of sterile Needle and Syringe Programming in reducing HIV/AIDS among injecting drug users, World Health Organization, Geneva.

  • World Health Organization (1986). Ottawa Charter for Health Promotion, First International Conference on Health Promotion Ottawa 17-21 November, 1986, WHO, Ottawa.

  • World Health Organization (2004). Evidence for action on HIV/AIDS and injecting drug use: Policy Brief: Provision of Sterile Injecting Equipment to Reduce HIV Transmission, World Health Organization, Geneva. World Health Organization (2006). Constitution of the World Health Organization, World Health Organization, Geneva.

  • World Health Organization (2006). Constitution of the World Health Organization, World Health Organization, Geneva.

  • World Health Organization and Joint United Nations Programme on HIV/AIDS (2007). Guide to Starting and Managing NSPs, World Health Organization, Geneva.
Top of page